Report also reveals a 35% increase in cancer indication approvals, and a 5x rise in pre- and postoperative approvals in the curative-intent setting ATLANTA – [December 14, 2021] – OncoHealth, the leading digital health company focused on the physical,...
Quarterly report also reveals 29% of approvals contained an immune checkpoint inhibitor and 43% were biomarker dependent ATLANTA – [September 27, 2021] – OncoHealth, the leading digital health company focused on the physical, mental and financial...
New name comes on the heels of major growth period and reflects the company’s expanding digital health portfolio ATLANTA – [September 20, 2021] – Oncology Analytics, the evidence-based digital health company purpose-built for oncology, announced today that...
Report shows 75% increase in new drug approvals compared to Q4 2020; Over 35% granted accelerated approval by the FDA ATLANTA – [June 10, 2021] – OncoHealth, the leading digital health company focused on the physical, mental and financial complexities of...
Company increased revenue YOY by 40%, delivered over $100 million of financial impact to clients, and added 1.1 million incremental new members on prior auth platform ATLANTA – [March 2, 2021] – OncoHealth, the leading digital health company focused on the...
Harvard Pilgrim Implements Real-World Data-Driven Prior Authorization Solution That Leverages Both Clinical and Claims Data ATLANTA, WELLESLEY – [October 13, 2020] – OncoHealth, the leading digital health company focused on the physical, mental and...
